BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28951008)

  • 1. Patient-specific bolus for range shifter air gap reduction in intensity-modulated proton therapy of head-and-neck cancer studied with Monte Carlo based plan optimization.
    Michiels S; Barragán AM; Souris K; Poels K; Crijns W; Lee JA; Sterpin E; Nuyts S; Haustermans K; Depuydt T
    Radiother Oncol; 2018 Jul; 128(1):161-166. PubMed ID: 28951008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
    de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
    Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
    Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
    van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
    Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
    Rana S; Greco K; Samuel EJJ; Bennouna J
    J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
    Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X
    Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A GPU-accelerated and Monte Carlo-based intensity modulated proton therapy optimization system.
    Ma J; Beltran C; Seum Wan Chan Tseung H; Herman MG
    Med Phys; 2014 Dec; 41(12):121707. PubMed ID: 25471954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
    Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
    Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
    Stützer K; Lin A; Kirk M; Lin L
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy.
    Ding X; Li X; Zhang JM; Kabolizadeh P; Stevens C; Yan D
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1107-1116. PubMed ID: 27869083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.
    Gu W; O'Connor D; Nguyen D; Yu VY; Ruan D; Dong L; Sheng K
    Med Phys; 2018 Apr; 45(4):1338-1350. PubMed ID: 29394454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
    Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
    Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
    Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically Applicable Monte Carlo-based Biological Dose Optimization for the Treatment of Head and Neck Cancers With Spot-Scanning Proton Therapy.
    Wan Chan Tseung HS; Ma J; Kreofsky CR; Ma DJ; Beltran C
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1535-1543. PubMed ID: 27325476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Online adaption approaches for intensity modulated proton therapy for head and neck patients based on cone beam CTs and Monte Carlo simulations.
    Botas P; Kim J; Winey B; Paganetti H
    Phys Med Biol; 2018 Dec; 64(1):015004. PubMed ID: 30524097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dosimetric comparison of intensity-modulated proton therapy optimization techniques for pediatric craniopharyngiomas: a clinical case study.
    Yeung D; McKenzie C; Indelicato DJ
    Pediatr Blood Cancer; 2014 Jan; 61(1):89-94. PubMed ID: 24000229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partitioning of discrete proton arcs into interlaced subplans can bring proton arc advances to existing proton facilities.
    Engwall E; Marthin O; Wase V; Sundström J; Mikhalev V; de Jong BA; Langendijk JA; Melbéus H; Andersson B; Korevaar EW; Both S; Bokrantz R; Glimelius L; Fredriksson A
    Med Phys; 2023 Sep; 50(9):5723-5733. PubMed ID: 37482909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shortening delivery times for intensity-modulated proton therapy by reducing the number of proton spots: an experimental verification.
    van de Water S; Belosi MF; Albertini F; Winterhalter C; Weber DC; Lomax AJ
    Phys Med Biol; 2020 May; 65(9):095008. PubMed ID: 32155594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive dosimetric study of Monte Carlo and pencil-beam algorithms on intensity-modulated proton therapy for breast cancer.
    Liang X; Li Z; Zheng D; Bradley JA; Rutenberg M; Mendenhall N
    J Appl Clin Med Phys; 2019 Jan; 20(1):128-136. PubMed ID: 30488548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.